Cancer Cachexia Market, Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: C59FDE4D9D59EN
Market Monitor Global

Abstracts

Cancer cachexia is a wasting syndrome characterized by weight loss, anorexia, asthenia and anemia. The pathogenicity of this syndrome is multifactorial, due to a complex interaction of tumor and host factors.

This report contains market size and forecasts of Cancer Cachexia in Global, including the following market information:

Global Cancer Cachexia Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cancer Cachexia market was valued at 1660.2 million in 2021 and is projected to reach US$ 2187.6 million by 2028, at a CAGR of 4.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Progestogens Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cancer Cachexia include Aeterna Zentaris, Alder BioPharmaceuticals, Aphios, Eli Lilly, GTx, Helsinn, Merck, Novartis and Bristol-Myers Squibb and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Cachexia companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cancer Cachexia Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cancer Cachexia Market Segment Percentages, by Type, 2021 (%)

• Progestogens
• Corticosteroids
• Combination Therapies
• Others

Global Cancer Cachexia Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cancer Cachexia Market Segment Percentages, by Application, 2021 (%)

• Hospital Stores
• Retails Pharmacy Store
• Online Pharmacy

Global Cancer Cachexia Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cancer Cachexia Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cancer Cachexia revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cancer Cachexia revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Aeterna Zentaris
• Alder BioPharmaceuticals
• Aphios
• Eli Lilly
• GTx
• Helsinn
• Merck
• Novartis
• Bristol-Myers Squibb
• XBiotech

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cancer Cachexia Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cancer Cachexia Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CANCER CACHEXIA OVERALL MARKET SIZE

2.1 Global Cancer Cachexia Market Size: 2021 VS 2028
2.2 Global Cancer Cachexia Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cancer Cachexia Players in Global Market
3.2 Top Global Cancer Cachexia Companies Ranked by Revenue
3.3 Global Cancer Cachexia Revenue by Companies
3.4 Top 3 and Top 5 Cancer Cachexia Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cancer Cachexia Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Cachexia Players in Global Market
  3.6.1 List of Global Tier 1 Cancer Cachexia Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cancer Cachexia Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cancer Cachexia Market Size Markets, 2021 & 2028
  4.1.2 Progestogens
  4.1.3 Corticosteroids
  4.1.4 Combination Therapies
  4.1.5 Others
4.2 By Type - Global Cancer Cachexia Revenue & Forecasts
  4.2.1 By Type - Global Cancer Cachexia Revenue, 2017-2022
  4.2.2 By Type - Global Cancer Cachexia Revenue, 2023-2028
  4.2.3 By Type - Global Cancer Cachexia Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cancer Cachexia Market Size, 2021 & 2028
  5.1.2 Hospital Stores
  5.1.3 Retails Pharmacy Store
  5.1.4 Online Pharmacy
5.2 By Application - Global Cancer Cachexia Revenue & Forecasts
  5.2.1 By Application - Global Cancer Cachexia Revenue, 2017-2022
  5.2.2 By Application - Global Cancer Cachexia Revenue, 2023-2028
  5.2.3 By Application - Global Cancer Cachexia Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cancer Cachexia Market Size, 2021 & 2028
6.2 By Region - Global Cancer Cachexia Revenue & Forecasts
  6.2.1 By Region - Global Cancer Cachexia Revenue, 2017-2022
  6.2.2 By Region - Global Cancer Cachexia Revenue, 2023-2028
  6.2.3 By Region - Global Cancer Cachexia Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cancer Cachexia Revenue, 2017-2028
  6.3.2 US Cancer Cachexia Market Size, 2017-2028
  6.3.3 Canada Cancer Cachexia Market Size, 2017-2028
  6.3.4 Mexico Cancer Cachexia Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cancer Cachexia Revenue, 2017-2028
  6.4.2 Germany Cancer Cachexia Market Size, 2017-2028
  6.4.3 France Cancer Cachexia Market Size, 2017-2028
  6.4.4 U.K. Cancer Cachexia Market Size, 2017-2028
  6.4.5 Italy Cancer Cachexia Market Size, 2017-2028
  6.4.6 Russia Cancer Cachexia Market Size, 2017-2028
  6.4.7 Nordic Countries Cancer Cachexia Market Size, 2017-2028
  6.4.8 Benelux Cancer Cachexia Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cancer Cachexia Revenue, 2017-2028
  6.5.2 China Cancer Cachexia Market Size, 2017-2028
  6.5.3 Japan Cancer Cachexia Market Size, 2017-2028
  6.5.4 South Korea Cancer Cachexia Market Size, 2017-2028
  6.5.5 Southeast Asia Cancer Cachexia Market Size, 2017-2028
  6.5.6 India Cancer Cachexia Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cancer Cachexia Revenue, 2017-2028
  6.6.2 Brazil Cancer Cachexia Market Size, 2017-2028
  6.6.3 Argentina Cancer Cachexia Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cancer Cachexia Revenue, 2017-2028
  6.7.2 Turkey Cancer Cachexia Market Size, 2017-2028
  6.7.3 Israel Cancer Cachexia Market Size, 2017-2028
  6.7.4 Saudi Arabia Cancer Cachexia Market Size, 2017-2028
  6.7.5 UAE Cancer Cachexia Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Aeterna Zentaris
  7.1.1 Aeterna Zentaris Corporate Summary
  7.1.2 Aeterna Zentaris Business Overview
  7.1.3 Aeterna Zentaris Cancer Cachexia Major Product Offerings
  7.1.4 Aeterna Zentaris Cancer Cachexia Revenue in Global Market (2017-2022)
  7.1.5 Aeterna Zentaris Key News
7.2 Alder BioPharmaceuticals
  7.2.1 Alder BioPharmaceuticals Corporate Summary
  7.2.2 Alder BioPharmaceuticals Business Overview
  7.2.3 Alder BioPharmaceuticals Cancer Cachexia Major Product Offerings
  7.2.4 Alder BioPharmaceuticals Cancer Cachexia Revenue in Global Market (2017-2022)
  7.2.5 Alder BioPharmaceuticals Key News
7.3 Aphios
  7.3.1 Aphios Corporate Summary
  7.3.2 Aphios Business Overview
  7.3.3 Aphios Cancer Cachexia Major Product Offerings
  7.3.4 Aphios Cancer Cachexia Revenue in Global Market (2017-2022)
  7.3.5 Aphios Key News
7.4 Eli Lilly
  7.4.1 Eli Lilly Corporate Summary
  7.4.2 Eli Lilly Business Overview
  7.4.3 Eli Lilly Cancer Cachexia Major Product Offerings
  7.4.4 Eli Lilly Cancer Cachexia Revenue in Global Market (2017-2022)
  7.4.5 Eli Lilly Key News
7.5 GTx
  7.5.1 GTx Corporate Summary
  7.5.2 GTx Business Overview
  7.5.3 GTx Cancer Cachexia Major Product Offerings
  7.5.4 GTx Cancer Cachexia Revenue in Global Market (2017-2022)
  7.5.5 GTx Key News
7.6 Helsinn
  7.6.1 Helsinn Corporate Summary
  7.6.2 Helsinn Business Overview
  7.6.3 Helsinn Cancer Cachexia Major Product Offerings
  7.6.4 Helsinn Cancer Cachexia Revenue in Global Market (2017-2022)
  7.6.5 Helsinn Key News
7.7 Merck
  7.7.1 Merck Corporate Summary
  7.7.2 Merck Business Overview
  7.7.3 Merck Cancer Cachexia Major Product Offerings
  7.7.4 Merck Cancer Cachexia Revenue in Global Market (2017-2022)
  7.7.5 Merck Key News
7.8 Novartis
  7.8.1 Novartis Corporate Summary
  7.8.2 Novartis Business Overview
  7.8.3 Novartis Cancer Cachexia Major Product Offerings
  7.8.4 Novartis Cancer Cachexia Revenue in Global Market (2017-2022)
  7.8.5 Novartis Key News
7.9 Bristol-Myers Squibb
  7.9.1 Bristol-Myers Squibb Corporate Summary
  7.9.2 Bristol-Myers Squibb Business Overview
  7.9.3 Bristol-Myers Squibb Cancer Cachexia Major Product Offerings
  7.9.4 Bristol-Myers Squibb Cancer Cachexia Revenue in Global Market (2017-2022)
  7.9.5 Bristol-Myers Squibb Key News
7.10 XBiotech
  7.10.1 XBiotech Corporate Summary
  7.10.2 XBiotech Business Overview
  7.10.3 XBiotech Cancer Cachexia Major Product Offerings
  7.10.4 XBiotech Cancer Cachexia Revenue in Global Market (2017-2022)
  7.10.5 XBiotech Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cancer Cachexia Market Opportunities & Trends in Global Market
Table 2. Cancer Cachexia Market Drivers in Global Market
Table 3. Cancer Cachexia Market Restraints in Global Market
Table 4. Key Players of Cancer Cachexia in Global Market
Table 5. Top Cancer Cachexia Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cancer Cachexia Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cancer Cachexia Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cancer Cachexia Product Type
Table 9. List of Global Tier 1 Cancer Cachexia Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Cachexia Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cancer Cachexia Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cancer Cachexia Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cancer Cachexia Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cancer Cachexia Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cancer Cachexia Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cancer Cachexia Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cancer Cachexia Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cancer Cachexia Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cancer Cachexia Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cancer Cachexia Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cancer Cachexia Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cancer Cachexia Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cancer Cachexia Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cancer Cachexia Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cancer Cachexia Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cancer Cachexia Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cancer Cachexia Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cancer Cachexia Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cancer Cachexia Revenue, (US$, Mn), 2023-2028
Table 30. Aeterna Zentaris Corporate Summary
Table 31. Aeterna Zentaris Cancer Cachexia Product Offerings
Table 32. Aeterna Zentaris Cancer Cachexia Revenue (US$, Mn), (2017-2022)
Table 33. Alder BioPharmaceuticals Corporate Summary
Table 34. Alder BioPharmaceuticals Cancer Cachexia Product Offerings
Table 35. Alder BioPharmaceuticals Cancer Cachexia Revenue (US$, Mn), (2017-2022)
Table 36. Aphios Corporate Summary
Table 37. Aphios Cancer Cachexia Product Offerings
Table 38. Aphios Cancer Cachexia Revenue (US$, Mn), (2017-2022)
Table 39. Eli Lilly Corporate Summary
Table 40. Eli Lilly Cancer Cachexia Product Offerings
Table 41. Eli Lilly Cancer Cachexia Revenue (US$, Mn), (2017-2022)
Table 42. GTx Corporate Summary
Table 43. GTx Cancer Cachexia Product Offerings
Table 44. GTx Cancer Cachexia Revenue (US$, Mn), (2017-2022)
Table 45. Helsinn Corporate Summary
Table 46. Helsinn Cancer Cachexia Product Offerings
Table 47. Helsinn Cancer Cachexia Revenue (US$, Mn), (2017-2022)
Table 48. Merck Corporate Summary
Table 49. Merck Cancer Cachexia Product Offerings
Table 50. Merck Cancer Cachexia Revenue (US$, Mn), (2017-2022)
Table 51. Novartis Corporate Summary
Table 52. Novartis Cancer Cachexia Product Offerings
Table 53. Novartis Cancer Cachexia Revenue (US$, Mn), (2017-2022)
Table 54. Bristol-Myers Squibb Corporate Summary
Table 55. Bristol-Myers Squibb Cancer Cachexia Product Offerings
Table 56. Bristol-Myers Squibb Cancer Cachexia Revenue (US$, Mn), (2017-2022)
Table 57. XBiotech Corporate Summary
Table 58. XBiotech Cancer Cachexia Product Offerings
Table 59. XBiotech Cancer Cachexia Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cancer Cachexia Segment by Type in 2021
Figure 2. Cancer Cachexia Segment by Application in 2021
Figure 3. Global Cancer Cachexia Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cancer Cachexia Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Cachexia Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Cachexia Revenue in 2021
Figure 8. By Type - Global Cancer Cachexia Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cancer Cachexia Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cancer Cachexia Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cancer Cachexia Revenue Market Share, 2017-2028
Figure 12. US Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cancer Cachexia Revenue Market Share, 2017-2028
Figure 16. Germany Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 17. France Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cancer Cachexia Revenue Market Share, 2017-2028
Figure 24. China Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 28. India Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cancer Cachexia Revenue Market Share, 2017-2028
Figure 30. Brazil Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cancer Cachexia Revenue Market Share, 2017-2028
Figure 33. Turkey Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cancer Cachexia Revenue, (US$, Mn), 2017-2028
Figure 37. Aeterna Zentaris Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Alder BioPharmaceuticals Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Aphios Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eli Lilly Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GTx Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Helsinn Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bristol-Myers Squibb Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. XBiotech Cancer Cachexia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)